About ARBOR VITA CORP
Arbor Vita Corporation develops rapid diagnostic tests for infectious diseases and cancers, including FDA-approved tests for influenza and cervical cancer. The company focuses on innovative proteomic and nucleic acid technologies to provide accessible, accurate, and timely diagnostic solutions.
Development of rapid diagnostic tests for infectious diseases and cancersCreation of FDA-approved and EUA-authorized tests (e.g., H5N1, H7N9, and SARS-CoV-2)Production of monoclonal antibodies for detection of HPV oncoproteins and influenza subtypesPoint-of-care diagnostics using PDZ domains and monoclonal antibodiesTesting in both advanced and remote healthcare settings
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ARBOR VITA CORP right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.